2023
Clinical predictive value of renalase in post-ERCP pancreatitis
Muniraj T, Desir G, Gorelick F, Guo X, Ciarleglio M, Deng Y, Jamidar P, Farrell J, Aslanian H, Laine L. Clinical predictive value of renalase in post-ERCP pancreatitis. Gastrointestinal Endoscopy 2023, 99: 822-825.e1. PMID: 38103747, DOI: 10.1016/j.gie.2023.12.020.Peer-Reviewed Original ResearchPost-ERCP pancreatitisRenalase levelsPlasma renalase levelsProspective cohort studyPotential clinical roleAcute experimental pancreatitisLongitudinal regression modelsPEP patientsPlasma renalaseCohort studyTertiary hospitalClinical roleExperimental pancreatitisRenalaseAbstractTextERCPPancreatitisFurther studiesAIMSRegression models
2021
Multicenter experience with digital single-operator cholangioscopy in pregnant patients
Gutierrez O, Brewer G, Zulli C, Tejaswi S, Pawa R, Jamidar P, Robles-Medranda C, Pawa S, Camilion JV, Oleas R, Parsa N, Runge T, Miaw D, Ichkhanian Y, Khashab MA. Multicenter experience with digital single-operator cholangioscopy in pregnant patients. Endoscopy International Open 2021, 09: e116-e121. PMID: 33532547, PMCID: PMC7834694, DOI: 10.1055/a-1320-0084.Peer-Reviewed Original ResearchPregnant patientsUse of fluoroscopyDigital single-operator cholangioscopySingle-operator cholangioscopyD-SOCStent removalModerate post-ERCP pancreatitisMedian birth weightMean gestational ageBile duct cannulationBile duct stonesPost-ERCP pancreatitisHalf of casesNeonatal outcomesMulticenter experienceTertiary centerDuct stonesGestational ageMild bleedingRetrograde cholangiopancreatographyRetrospective studyBirth weightDuct cannulationTechnical successAvoidance of radiation
2020
Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis
Njei B, McCarty TR, Muniraj T, Sharma P, Jamidar PA, Aslanian HR, Varadarajulu S, Navaneethan U. Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis. Endoscopy International Open 2020, 08: e29-e40. PMID: 31921982, PMCID: PMC6949176, DOI: 10.1055/a-1005-6366.Peer-Reviewed Original ResearchRectal non-steroidal anti-inflammatory drugsNon-steroidal anti-inflammatory drugsPost-ERCP pancreatitisPancreatic stent placementHigh-risk patientsStent placementEndoscopic interventionPreventive strategiesPost-endoscopic retrograde cholangiopancreatography pancreatitisCumulative ranking (SUCRA) probabilitiesEffective preventive strategiesAnti-inflammatory drugsWeb of ScienceAggressive hydrationSUCRA probabilitiesCholangiopancreatography pancreatitisCochrane DatabaseProphylactic treatmentPancreatic stentPancreatitisComparative effectivenessSystematic reviewRanking probabilityCombination of LRPatients
2015
Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study
Yaghoobi M, Pauls Q, Durkalski V, Romagnuolo J, Fogel EL, Tarnasky PR, Aliperti G, Freeman ML, Kozarek RA, Jamidar PA, Wilcox CM, Elta GH, Hawes RH, Wood-Williams A, Cotton PB. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study. Endoscopy 2015, 47: 884-890. PMID: 26165739, DOI: 10.1055/s-0034-1392418.Peer-Reviewed Original ResearchMeSH KeywordsAdultCholangiopancreatography, Endoscopic RetrogradeCommon Bile Duct DiseasesFemaleFollow-Up StudiesHumansIncidenceMaleManometryMiddle AgedPancreatitisPostoperative ComplicationsPressurePrognosisProspective StudiesSphincter of OddiSphincter of Oddi DysfunctionSphincterotomy, EndoscopicStentsUnited StatesYoung AdultConceptsPost-ERCP pancreatitisEndoscopic retrograde cholangiopancreatographyDual sphincterotomySedation typeOddi dysfunctionDevelopment of PEPRisk of PEPLife-threatening adverse eventsPancreatic sphincter pressuresPost-cholecystectomy patientsResults of sphincterSOD type IIIProphylactic pancreatic stentsSham-controlled studyEvaluating PredictorsPharmacological prophylaxisERCP pancreatitisProspective multicenterOddi manometryPancreatic stentingSphincter pressureAdverse eventsSham armBiliary sphincterotomyAcute pancreatitisEndoscopic Retrograde Cholangiopancreatography–Related Adverse Events General Overview
Rustagi T, Jamidar PA. Endoscopic Retrograde Cholangiopancreatography–Related Adverse Events General Overview. Gastrointestinal Endoscopy Clinics Of North America 2015, 25: 97-106. PMID: 25442961, DOI: 10.1016/j.giec.2014.09.005.Peer-Reviewed Original ResearchConceptsEndoscopic retrograde cholangiopancreatographyAdverse eventsRetrograde cholangiopancreatographyERCP-related adverse eventsProcedure-related risk factorsOverall adverse event rateAdverse event ratesManagement of patientsPost-ERCP pancreatitisRoutine endoscopic proceduresRisk factorsPancreaticobiliary diseasesEndoscopic proceduresEvent ratesCholangiopancreatographyMonumental advancesInherent risksHigher inherent riskBleedingPancreatitisSedationPatientsInfectionDiseaseDiagnosis
2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointestinal Endoscopy 2005, 62: 245-250. PMID: 16046988, DOI: 10.1016/s0016-5107(05)01572-5.Peer-Reviewed Original ResearchConceptsPost-ERCP pancreatitisOral allopurinolAllopurinol groupControl groupOxygen-derived free radical productionPlacebo 4 hoursProcedure risk factorsCommon major complicationSeverity of pancreatitisFree radical productionProphylactic allopurinolPatient demographicsMajor complicationsOverall incidencePostprocedure pancreatitisPharmacologic agentsRisk factorsPancreatitisPatientsStandardized criteriaAllopurinolERCPSeveritySignificant differencesIncidence